Biome Australia Limited Appendix 4E Preliminary final report
The Company continued to experience strong sales growth during the year with revenue increasing by 75.5% to $7,235,611
compared to the previous corresponding period (FY22 $4,122,425). The strong sales growth has been driven by Biome’s
Activated Probiotics, range of live biotherapeutics (probiotics).
ASX Announcement